← Back to Clinical Trials
Recruiting NCT06770075

NCT06770075 Brightline: Advancing Mental Health on Campus

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06770075
Status Recruiting
Phase
Sponsor Nanyang Technological University
Condition Depression
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2025-01
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 25 Years
Study Type OBSERVATIONAL
Interventions
Observational

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2025-01 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study will employ a multi-modal observation methodology, integrating data from wearable devices and smartphones to establish comprehensive digital biomarkers for identifying symptoms of mental health conditions in university students. The study aims to identify the digital behavioural markers associated with mental health conditions, develop predictive algorithms for mental health states from digital markers, and identify university students at risk for mental health conditions.

Eligibility Criteria

Inclusion Criteria: * Be aged 18 years or older. * Be a current full-time undergraduate student. * Own a smartphone with Wi-Fi, 4G, and Bluetooth capabilities. * Possess adequate English language proficiency. * Be able to download the study apps. * Provide informed consent. Exclusion Criteria: * Are part-time students. * Have a current diagnosis of any mental health disorder or a past diagnosis with any bipolar disorder, substance use disorder, or any psychotic disorder. * Are currently undergoing mental health treatment. * Lack sufficient English proficiency. * Report suicidal ideation as indicated by Patient Health Questionnaire (PHQ-9) Item-9, "Thoughts you would be better off dead or of hurting yourself in some way". * Cannot commit to wearing a wearable device for the six-month monitoring period. * Receive special education accommodations or support from the university.

Contact & Investigator

Central Contact

Zhi Wei Tan, PhD

✉ zhiwei.tan@ntu.edu.sg

📞 +65 92312575

Principal Investigator

Andy WH Khong, PhD

PRINCIPAL INVESTIGATOR

Nanyang Technological University

Frequently Asked Questions

Who can join the NCT06770075 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06770075 currently recruiting?

Yes, NCT06770075 is actively recruiting participants. Contact the research team at zhiwei.tan@ntu.edu.sg for enrollment information.

Where is the NCT06770075 trial being conducted?

This trial is being conducted at Singapore, Singapore.

Who is sponsoring the NCT06770075 clinical trial?

NCT06770075 is sponsored by Nanyang Technological University. The principal investigator is Andy WH Khong, PhD at Nanyang Technological University. The trial plans to enroll 500 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology